In its March 12, 2024 decision upholding Arkansas’ 340B Drug Pricing Nondiscrimination Act, the U.S. Court of Appeals for the 8th Circuit said the following: Act 1103 does not create an obstacle ...

The U.S. Supreme Court refused to hear an appeal by a pharmaceutical industry group challenging Arkansas' 340B drug pricing law. The decision last Monday affirms a lower court's ruling in March ...

The 340B Program has continued to undergo significant upheaval in 2024 that has the potential to bring about impactful changes to how the 340B ...

Drugmakers turned to the Supreme Court after a district and appellate court upheld an Arkansas law that ensures providers get the same 340B drug discounts for prescriptions dispensed at community ...

The Supreme Court has upheld Arkansas' 340B drug pricing law, rejecting a legal challenge from the Pharmaceutical Research and Manufacturers of America against the state's regulation. The decision ...

In 2020, many began imposing restrictions on 340B drug sales using contract pharmacies. Arkansas in 2021 became the first state to pass a law against that practice. PhRMA claimed in its lawsuit ...

It states that Act 1103 prohibits drug company policies that restrict dispensing 340B drugs through community and specialty pharmacy partners. In response, Arkansas Attorney General Tim Griffin ...

Arkansas Attorney General Tim Griffin and 29 state coalition make opioid settlement with Kroger Act 1103 prohibits drug company policies restricting dispensing 340B drugs through community and ...

In 2020, many began imposing restrictions on 340B drug sales using contract pharmacies. West Virginia and other states, including Arkansas, Mississippi, Kansas and Louisiana, have passed laws ...